Menu

China Biologic Products Holdings, Inc. CBPO

Full chart Compare
Set alert

Price alert · CBPO

All alert types
— —

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $344.43MGross Profit → Net Income: $152.29MGross Profit → Selling, General & Admin: $140.47MRevenue → Cost of Revenue: $179.94MGross Profit → Research & Development: $8.58MGross Profit → Interest Expense: $324.06KGross Profit → Other Expenses: $7.03MGross Profit → Income Tax: $35.74MGross Profit$344.43MCost of Revenue$179.94MNet Income$152.29MSelling, General & Admin$140.47MResearch & Development$8.58MInterest Expense$324.06KOther Expenses$7.03MIncome Tax$35.74MRevenue$524.37M

Latest period ending Dec 31, 2020 · select a line to chart its full history

CBPO annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
524.37M503.74M466.88M370.41M341.17M
344.43M329.08M320.09M244.89M217.13M
195.37M163.65M146.17M135.86M143.91M
152.29M138.81M128.06M67.94M104.78M
3.823.533.532.383.74
CBPO annual balance sheet
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
682.80M659.43M876.36M242.23M183.77M
2.26B1.94B2.01B809.06M604.96M
177.73M163.01M165.28M144.73M83.82M
1.98B1.70B1.72B598.19M462.20M
CBPO annual cash flow
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
258.48M229.34M103.94M102.18M123.26M
263.01M-180.14M-558.95M-60.90M-52.52M
-12.07M-229.47M571.30M-18.32M-22.08M
-18.90M-19.72M-31.62M-37.44M-38.68M
513.58M-177.13M119.54M35.57M38.83M